Works matching AU Heuvel, Michel M van den

Results: 57
    1

    Implementation of a Multicenter Biobanking Collaboration for Next-Generation Sequencing-Based Biomarker Discovery Based on Fresh Frozen Pretreatment Tumor Tissue Biopsies.

    Published in:
    Oncologist, 2017, v. 22, n. 1, p. 33, doi. 10.1634/theoncologist.2016-0085
    By:
    • Bins, Sander;
    • Cirkel, Geert A.;
    • Gadellaa‐Van Hooijdonk, Christa G.;
    • Weeber, Fleur;
    • Numan, Isaac J.;
    • Bruggink, Annette H.;
    • van Diest, Paul J.;
    • Willems, Stefan M.;
    • Veldhuis, Wouter B.;
    • van den Heuvel, Michel M.;
    • de Knegt, Rob J.;
    • Koudijs, Marco J.;
    • van Werkhoven, Erik;
    • Mathijssen, Ron H.J.;
    • Cuppen, Edwin;
    • Sleijfer, Stefan;
    • Schellens, Jan H.M.;
    • Voest, Emile E.;
    • Langenberg, Marlies H.G.;
    • de Jonge, Maja J.A.
    Publication type:
    Article
    2
    3
    4
    5

    Combining variant detection and fragment length analysis improves detection of minimal residual disease in postsurgery circulating tumour DNA of stage II-IIIA NSCLC patients.

    Published in:
    Molecular Oncology, 2022, v. 16, n. 14, p. 2719, doi. 10.1002/1878-0261.13267
    By:
    • Vessies, Daan C. L.;
    • Schuurbiers, Milou M. F.;
    • van der Noort, Vincent;
    • Schouten, Irene;
    • Linders, Theodora C.;
    • Lanfermeijer, Mirthe;
    • Ramkisoensing, Kalpana L.;
    • Hartemink, Koen J.;
    • Monkhorst, Kim;
    • van den Heuvel, Michel M.;
    • van den Broek, Daan
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Renal function-based versus standard dosing of pemetrexed: a randomized controlled trial.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2023, v. 91, n. 1, p. 33, doi. 10.1007/s00280-022-04489-1
    By:
    • de Rouw, Nikki;
    • Boosman, René J.;
    • Burgers, Jacobus A.;
    • Huitema, Alwin D. R.;
    • Dingemans, Anne-Marie C.;
    • Derijks, Hieronymus. J.;
    • Burger, David M.;
    • Piet, Berber;
    • Hendriks, Lizza E. L.;
    • Biesma, Bonne;
    • Pruis, Melinda A.;
    • Dumoulin, Daphne W.;
    • Croes, Sander;
    • Mathijssen, Ron H. J.;
    • van den Heuvel, Michel M.;
    • ter Heine, Rob
    Publication type:
    Article
    16
    17
    18
    19
    20
    21

    Model-Informed Development of a Cost-Saving Dosing Regimen for Sacituzumab Govitecan.

    Published in:
    Targeted Oncology, 2024, v. 19, n. 5, p. 789, doi. 10.1007/s11523-024-01075-8
    By:
    • Moes, Dirk J. A. R.;
    • Hendrikx, Jeroen J. M. A.;
    • Guchelaar, Henk-Jan;
    • Mathijssen, Ron H. J.;
    • Bakker, J. L.;
    • Dezentjé, Vincent O.;
    • de Rouw, Nikki;
    • van Erp, Nielka P.;
    • Smit, Egbert F.;
    • van den Heuvel, Michel M.;
    • Munnink, Thijs H. Oude;
    • van Kats, Maartje;
    • Croes, Sander;
    • Kroep, Judith R.;
    • Zwaveling, Juliette;
    • ter Heine, Rob
    Publication type:
    Article
    22

    A Systematic Evaluation of Cost-Saving Dosing Regimens for Therapeutic Antibodies and Antibody-Drug Conjugates for the Treatment of Lung Cancer.

    Published in:
    Targeted Oncology, 2023, v. 18, n. 3, p. 441, doi. 10.1007/s11523-023-00958-6
    By:
    • ter Heine, Rob;
    • van den Heuvel, Michel M.;
    • Piet, Berber;
    • Deenen, Maarten J.;
    • van der Wekken, Anthonie J.;
    • Hendriks, Lizza E. L.;
    • Croes, Sander;
    • van Geel, Robin M. J. M.;
    • Jansman, Frank G. A.;
    • Boshuizen, Rogier C.;
    • Franssen, Eric J. F.;
    • Smit, Arthur A. J.;
    • Dumoulin, Daphne W.;
    • Oude Munnink, Thijs H.;
    • Smit, Egbert F.;
    • Derijks, Hieronymus J.;
    • van der Leest, Cor H.;
    • Hendrikx, Jeroen J. M. A.;
    • Moes, Dirk J. A. R.;
    • de Rouw, Nikki
    Publication type:
    Article
    23
    24
    25
    26
    27

    Hyperhydration with cisplatin does not influence pemetrexed exposure.

    Published in:
    British Journal of Clinical Pharmacology, 2022, v. 88, n. 2, p. 871, doi. 10.1111/bcp.15031
    By:
    • de Rouw, Nikki;
    • Derijks, Hieronymus J.;
    • Hilbrands, Luuk B.;
    • Boosman, René J.;
    • Piet, Berber;
    • Koolen, Stijn L. W.;
    • Burgers, Jacobus A.;
    • Dingemans, Anne‐Marie C.;
    • van den Heuvel, Michel M.;
    • Hendriks, Lizza E. L.;
    • Aerts, Joachim G. J. V.;
    • Croes, Sander;
    • Mathijssen, Ron H. J.;
    • Huitema, Alwin D. R.;
    • Burger, David M.;
    • Biesma, Bonne;
    • ter Heine, Rob
    Publication type:
    Article
    28

    Polyfunctional tumor-reactive T cells are effectively expanded from non-small cell lung cancers, and correlate with an immune-engaged T cell profile.

    Published in:
    OncoImmunology, 2019, v. 8, n. 11, p. 1, doi. 10.1080/2162402X.2019.1648170
    By:
    • De Groot, Rosa;
    • Van Loenen, Marleen M.;
    • Guislain, Aurélie;
    • Nicolet, Benoît P.;
    • Freen-Van Heeren, Julian J.;
    • Verhagen, Onno J.H.M.;
    • Van Den Heuvel, Michel M.;
    • De Jong, Jeroen;
    • Burger, Patrick;
    • Van Der Schoot, C.Ellen;
    • Spaapen, Robbert M.;
    • Amsen, Derk;
    • Haanen, John B. A. G.;
    • Monkhorst, Kim;
    • Hartemink, Koen J.;
    • Wolkers, Monika C.
    Publication type:
    Article
    29

    Importance of tumour volume and histology in trimodality treatment of patients with Stage IIIA non-small cell lung cancer—results from a retrospective analysis.

    Published in:
    Interactive Cardiovascular & Thoracic Surgery, 2022, v. 34, n. 4, p. 566, doi. 10.1093/icvts/ivab291
    By:
    • Joosten, Pieter J M;
    • Dickhoff, Chris;
    • van der Noort, Vincent;
    • Smeekens, Maarten;
    • Numan, Rachel C;
    • Klomp, Houke M;
    • Diessen, Judi N A van;
    • Belderbos, Jose S A;
    • Smit, Egbert F;
    • Monkhorst, Kim;
    • Oosterhuis, Jan W A;
    • Heuvel, Michel M van den;
    • Dahele, Max;
    • Hartemink, Koen J
    Publication type:
    Article
    30

    Implementation of Novel Molecular Biomarkers for Non-small Cell Lung Cancer in the Netherlands: How to Deal With Increasing Complexity.

    Published in:
    Frontiers in Oncology, 2020, v. 9, p. 1, doi. 10.3389/fonc.2019.01521
    By:
    • van den Broek, Daan;
    • Hiltermann, T. Jeroen N.;
    • Biesma, Bonne;
    • Dinjens, Winand N. M.;
    • 't Hart, Nils A.;
    • Hinrichs, John W. J.;
    • Leers, Mathie P. G.;
    • Monkhorst, Kim;
    • van Oosterhout, Matthijs;
    • Scharnhorst, Volkher;
    • Schuuring, Ed;
    • Speel, Ernst-Jan M.;
    • van den Heuvel, Michel M.;
    • van Schaik, Ron H. N.;
    • von der Thüsen, Jan;
    • Willems, Stefan M.;
    • de Visser, Leonie;
    • Ligtenberg, Marjolijn J. L.
    Publication type:
    Article
    31

    Implementation of Novel Molecular Biomarkers for Non-small Cell Lung Cancer in the Netherlands: How to Deal With Increasing Complexity.

    Published in:
    Frontiers in Oncology, 2020, v. 10, p. 1, doi. 10.3389/fonc.2019.01521
    By:
    • van den Broek, Daan;
    • Hiltermann, T. Jeroen N.;
    • Biesma, Bonne;
    • Dinjens, Winand N. M.;
    • 't Hart, Nils A.;
    • Hinrichs, John W. J.;
    • Leers, Mathie P. G.;
    • Monkhorst, Kim;
    • van Oosterhout, Matthijs;
    • Scharnhorst, Volkher;
    • Schuuring, Ed;
    • Speel, Ernst-Jan M.;
    • van den Heuvel, Michel M.;
    • van Schaik, Ron H. N.;
    • von der Thüsen, Jan;
    • Willems, Stefan M.;
    • de Visser, Leonie;
    • Ligtenberg, Marjolijn J. L.
    Publication type:
    Article
    32
    33
    34
    35
    36

    Recurrence prediction using circulating tumor DNA in patients with early-stage non-small cell lung cancer after treatment with curative intent: A retrospective validation study.

    Published in:
    PLoS Medicine, 2025, v. 22, n. 4, p. 1, doi. 10.1371/journal.pmed.1004574
    By:
    • Schuurbiers, Milou M. F.;
    • Smith, Christopher G.;
    • Hartemink, Koen J.;
    • Rintoul, Robert C.;
    • Gale, Davina;
    • Monkhorst, Kim;
    • Mandos, Bas L. R.;
    • Paterson, Anna L.;
    • van den Broek, Dan;
    • Rosenfeld, Nitzan;
    • van den Heuvel, Michel M.
    Publication type:
    Article
    37
    38

    The Toxicity Profile of Pemetrexed in Non-Small Cell Lung Cancer Patients With Moderate Renal Impairment: A Retrospective Cohort Study.

    Published in:
    Clinical Lung Cancer, 2025, v. 26, n. 4, p. 324, doi. 10.1016/j.cllc.2025.03.010
    By:
    • Kicken, Mart P.;
    • Heine, Rob Ter;
    • Azarfane, Intissar;
    • de Rouw, Nikki;
    • de Vries, Fenna;
    • Peters, Bas J. M.;
    • Lankheet, Nienke A. G.;
    • Eektimmerman, Frank;
    • Beerden, Tim;
    • Franssen, Eric J. F.;
    • Krens, Lisanne L.;
    • van der Leest, Cor H.;
    • Smit, Arthur A. J.;
    • Polman, Albert J.;
    • Vermeer, Laura C.;
    • van Putten, John W. G.;
    • van den Borne, Ben E. E. M.;
    • van den Heuvel, Michel M.;
    • Deenen, Maarten J.
    Publication type:
    Article
    39
    40
    41

    Therapeutic drug monitoring guided dosing versus standard dosing of alectinib in advanced ALK positive non-small cell lung cancer patients: Study protocol for an international, multicenter phase IV randomized controlled trial (ADAPT ALEC).

    Published in:
    Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1136221
    By:
    • Meertens, Marinda;
    • Muntinghe-Wagenaar, M. Benthe;
    • Sikkema, Barend J.;
    • Lopez-Yurda, Marta;
    • Retèl, Valesca P.;
    • Paats, Marthe S.;
    • Heine, Rob Ter;
    • Schuuring, Ed;
    • Timens, Wim;
    • Touw, Daan J.;
    • van Boven, Job F. M.;
    • de Langen, Adrianus. J.;
    • Hashemi, Sayed M. S.;
    • Hendriks, Lizza E. L.;
    • Croes, Sander;
    • van den Heuvel, Michel M.;
    • Dingemans, Anne-Marie C.;
    • Mathijssen, Ron H. J.;
    • Smit, Egbert F.;
    • Huitema, Alwin D. R.
    Publication type:
    Article
    42
    43

    Sorafenib synergizes with metformin in NSCLC through AMPK pathway activation.

    Published in:
    International Journal of Cancer, 2015, v. 136, n. 6, p. 1434, doi. 10.1002/ijc.29113
    By:
    • Groenendijk, Floris H.;
    • Mellema, Wouter W.;
    • van der Burg, Eline;
    • Schut, Eva;
    • Hauptmann, Michael;
    • Horlings, Hugo M.;
    • Willems, Stefan M.;
    • van den Heuvel, Michel M.;
    • Jonkers, Jos;
    • Smit, Egbert F.;
    • Bernards, René
    Publication type:
    Article
    44

    Absence of PD-L1 expression on tumor cells in the context of an activated immune infiltrate may indicate impaired IFNγ signaling in non-small cell lung cancer.

    Published in:
    PLoS ONE, 2019, v. 14, n. 5, p. 1, doi. 10.1371/journal.pone.0216864
    By:
    • Theelen, Willemijn S. M. E.;
    • Kuilman, Thomas;
    • Schulze, Katja;
    • Zou, Wei;
    • Krijgsman, Oscar;
    • Peters, Dennis D. G. C.;
    • Cornelissen, Sten;
    • Monkhorst, Kim;
    • Sarma, Pranamee;
    • Sumiyoshi, Teiko;
    • Amler, Lukas C.;
    • Willems, Stefan M.;
    • Blaauwgeers, Johannes L. G.;
    • van Noesel, Carel J. M.;
    • Peeper, Daniel S.;
    • van den Heuvel, Michel M.;
    • Kowanetz, Marcin
    Publication type:
    Article
    45
    46
    47
    48
    49

    Mechanisms of Immune Checkpoint Inhibitor-Mediated Colitis.

    Published in:
    Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.768957
    By:
    • Westdorp, Harm;
    • Sweep, Mark W. D.;
    • Gorris, Mark A. J.;
    • Hoentjen, Frank;
    • Boers-Sonderen, Marye J.;
    • Post, Rachel S. van der;
    • Heuvel, Michel M. van den;
    • Piet, Berber;
    • Boleij, Annemarie;
    • Bloemendal, Haiko J.;
    • de Vries, I. Jolanda M.
    Publication type:
    Article
    50